SCHEMBL24065798

SCHEMBL24065798

N#Cc1ccc(-c2ccc(-c3ccc(-c4ccc(-c5nc(-c6cccc7ccccc67)c6ccccc6n5)cc4)c4ccccc34)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 7/20 0.48
KDM1A O60341 1/20 0.44
MEN1 O00255 7/20 0.44
KMT2A Q03164 7/20 0.44
CYP1A2 P05177 5/20 0.44
CYP2C19 P33261 4/20 0.44
ALDH1A1 P00352 4/20 0.44
CYP3A4 P08684 3/20 0.44
CLK4 Q9HAZ1 3/20 0.44
LMNA P02545 3/20 0.44
HSD17B10 Q99714 3/20 0.44
CYP2C9 P11712 2/20 0.44
TSHR P16473 2/20 0.44
CYP2D6 P10635 2/20 0.44
ATM Q13315 2/20 0.43
MAPK1 P28482 2/20 0.41
SLC22A12 Q96S37 1/20 0.41
ADORA2A P29274 1/20 0.41
KDM4E B2RXH2 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24065744 1.00 ABCG2 (0.48) ABCG2KDM1AMEN1KMT2ACYP1A2
SCHEMBL24065823 0.98 ABCG2 (0.48) ABCG2KDM1AMEN1KMT2ACYP1A2
SCHEMBL24065774 0.96 ABCG2 (0.51) ABCG2KDM1AMEN1KMT2ACYP1A2
SCHEMBL24065794 0.95 MEN1 (0.49) ABCG2KDM1AMEN1KMT2ACYP1A2
SCHEMBL24065726 0.95 MEN1 (0.49) ABCG2KDM1AMEN1KMT2ACYP1A2
SCHEMBL24065828 0.95 ABCG2 (0.43) ABCG2KDM1AMEN1KMT2ACYP1A2
SCHEMBL24065795 0.95 ABCG2 (0.43) ABCG2KDM1AMEN1KMT2ACYP1A2
SCHEMBL24065825 0.94 MEN1 (0.50) ABCG2KDM1AMEN1KMT2ACYP1A2
SCHEMBL24065811 0.93 MEN1 (0.49) ABCG2KDM1AMEN1KMT2ACYP1A2
SCHEMBL24065831 0.92 ABCG2 (0.55) ABCG2KDM1AMEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC4, CRY1, TRPC1 ABCG2 3187/4885KDM1A 1367/4885MEN1 780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.